FDA Approved: IVERMECTIN — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Actavis Pharma’s ivermectin, confirming approval of its generic antiparasitic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onchocerciasis
• Scabies
• Strongyloidiasis

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

SUPPL AP for IVERMECTIN (IVERMECTIN)